Five vendors have come together to form a collaborative to help state leaders accelerate their efforts in the RHT Program.

Strand Therapeutics, a leader in next-generation mRNA-based therapeutics, today announced the promotion of Prashant Nambiar, DVM, PhD, MBA, as Chief Scientific Officer and appointment of Ethan Cash as ...

OmniAb, Inc. (NASDAQ: OABI) today reported financial results for the three and nine months ended September 30, 2025, and provided operating and partner program updates.

Efficient cell line development remains one of the most critical challenges in biotherapeutic manufacturing. Achieving stable, high-yield expression systems while maintaining product quality and ...

Columbus Business First President & Publisher Nick Fortine speaks with experts from Trace3 and Cisco about how organizations ...

Just how automated the B-21 is remains unclear, but officials pushing to fly it with just one pilot points to a breakthrough ...

Interactions with FDA Progressing Towards December 26, 2025 PDUFA Date for Aficamten; U.S. Commercial Launch Preparations on TrackEx-U.S.

The engagement is focused on helping Morrisons advance its strategic priorities by enhancing operational efficiency, ...

Authored by certified embedded ML specialists with extensive experience in ESP32 voice recognition architecture, TinyML ...

In 2025, the SEC issued its first digital-asset no-action letter in years to DoubleZero, signaling a more supportive approach ...

DELAWARE, Ohio, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Greif, Inc. (NYSE: GEF, GEF.B), a world leader in industrial packaging products and services, today announced two-month fourth quarter and ...

Milestone advances two-part study evaluating novel, locally administered gene therapy designed to increase anti-inflammatory ...